Kiniksa Pharmaceuticals International, plc
(KNSA - NASDAQ)
77,91 USD
📋 Profilo Aziendale

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

|